Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

GLC Biotechnology Inc (AKA: GLC)
Profile last edited on: 7/6/18      CAGE: 47K43      UEI: ETKMDA959PF6

Business Identifier: Novel technology for DNA methylation analysis
Year Founded
2002
First Award
2004
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

7362 Stcokwood Drive
Solon, OH 44139
   (330) 405-0858
   glc@glcbiotech.com
   www.glcbiotech.com
Location: Single
Congr. District: 14
County: 

Public Profile

GLC Biotechnology, Inc. is identified in BioOhio as developing a novel technology for DNA methylation analysis. The method is designed to be more sensitive, specific and cost effective than currently available methods. The company’s initial focus will be on new diagnostics for colorectal and other cancers. Principal of the firm is associated to University. Firm appears to have discontinued business operation

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
3
Conversion Rate
42.86%
Phase I Dollars
$1,139,351
Phase II Dollars
$4,642,256
Total Awarded
$5,781,607

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 2 NIH $1,500,001
Project Title: A Novel Method for Efficiently and Robustly Retrieving Circulating miRNAs
2018 1 NIH $225,000
Project Title: Development of a Novel Liquid Biopsy Test to Assist Targeted Msi-H Cancer Treatment
2016 1 NIH $225,000
Project Title: A Method for Quantitatively Retrieving Circulating miRNAs from Plasma
2014 1 NIH $225,000
Project Title: Fecal Dna Testing For Colorectal Cancer Screening
2010 2 NIH $2,018,645
Project Title: MMPA: a Novel Multiplexing Methylation Analysis Technology

Key People / Management

  Baochuan Guo -- President

  Qipan Deng -- Senior Scientist

Company News

There are no news available.